Nucleoproteins and protein synthesis machinery

The term Nucleoproteins and protein synthesis machinery describes a diverse collective of molecular entities essential for translating genetic codes into proteins and maintaining genomic or viral structural integrity. This category primarily encompasses the ribosome—a complex ribozyme composed of small and large subunits—along with auxiliary factors such as aminoacyl-tRNA synthetases and translation factors [1]. In the context of pharmacology, these components are most notably targeted by a wide range of antibiotics, including aminoglycosides, tetracyclines, and macrolides, which exploit structural differences between prokaryotic and eukaryotic ribosomes to achieve selective toxicity [2]. Beyond bacteria, viral nucleoproteins serve as critical scaffolds for viral RNA/DNA, playing indispensable roles in the replication cycles of pathogens like influenza and SARS-CoV-2 [3]. Because this designation refers to an entire functional system rather than a single protein or receptor, it is typically used as a high-level classification for drugs that disrupt protein production or viral assembly. Consequently, therapeutic interventions targeting this machinery are vital for treating infectious diseases, though they face challenges such as the development of antimicrobial resistance and potential off-target effects on human mitochondrial ribosomes [4].

Other names

Translation machineryRibosomal complexProtein synthesis apparatusNucleoprotein complex

Inhibition of protein synthesis by binding to ribosomal subunits (30S or 50S), preventing peptide bond formation, or causing mRNA misreading; interference with viral nucleoprotein-RNA interactions.